Preliminary experience in the use of CERA occluders for ... | 合法醫療器材資訊網

由RFiszer著作·2014·被引用10次—Wepresentourpreliminaryexperienceintranscatheterclosureofatrialseptaldefect(ASD),patentforamenovale(PFO),patentductusarteriosus(PDA),andpost- ...

Background: Transcatheter closure has become the method of choice for treatment of many heart defects. Recently, Lifetech Scientific introduced the Cera occluder (CO), a self-expandable nitinol wire-mesh device covered with ceramic coating. We present our preliminary experience in transcatheter closure of atrial septal defect (ASD), patent foramen ovale (PFO), patent ductus arteriosus (PDA), and post-infarction ventricular septal defect (PIVSD) with the CO.

Methods: The study population consisted of 25 patients (17 female) ages 1.1-82 years (median age, 34.0 years) with either ASD (n = 7), PFO (n = 11), PDA (n = 6), or PIVSD (n = 1). All patients were treated percutaneously with appropriate CO devices, without any preliminary patient selection. The implantation technique applied in these procedures was the same as previously described for Amplatzer occluders.

Results: All procedures...